medical-devices-fund-2014

Bone Substitute MaterialSr-HT-Gahnite presents a major advance insynthetic materials by combining a highly porousand interconnected scaffold with outstandingmechanical and bioactive properties forregenerating large bone defects under load.There is no perceived restriction for the productas it has the potential for use in non-load bearingas well as load bearing applications in all ages.There are no synthetic alternatives to Sr-HT-Gahnite as all options are indicated for nonstructurallyintegral uses. The current practice toaddress load bearing implants is through eithermetal only, with slow to no bone integration, orthrough autogenic and allogeneic implants withtheir inherent disadvantages.Bone graft products are used in a wide range oforthopaedic surgery applications; fusing joints toprevent movement in the spine and/orextremities; repair injured bone/joints;accelerating repair of fractures with bone loss, orsimply repair bone voids from surgery, trauma,removal of bone tumour, disease and/or infection.“The NSW Medical Devices Fund isfocused on the translation of researchinto commercial products. The winningenterprises are all fine examples ofresearch that has true commercialpotential and the ability to contributeto the development of the medicaldevice industry in New South Wales.”Neville MitchellNSW Medical DevicesFund Panel MemberThe clinical relevance of Sr HT-Gahnite’s potentialinclude reduced morbidity associated with asecond surgical procedure, reduced infection risk,reduced medication and based on the preclinicalevidence to date, there is the potential for morerapid bone growth leading to improved patientrecovery rates.Allegra is a publicly listed company on the ASXand its sales, design and manufacturing team isbased in St Leonards at its 2,000m 2manufacturing facility.Public/Private CompanyStage/CategoryPublic ASX: AMTPre-clinical medical deviceswith orthopaedic revenuesWebsiteContactwww.allegraorthopaedics.comTom Milicevic, CEOEmail: tom.milicevic@allegraorthopaedics.comPhone: +61 402 304 015Medical Devices Fund 2014 NSW HEALTH 5